Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OCUL Ocular Therapeutix

盘后交易 07-16 19:46:24 EDT

8.40

-0.03

-0.36%

盘后8.30

-0.10-1.19%

19:37 EDT

最高8.68	最低8.30	成交量272.02万
今开8.54	昨收8.43	日振幅4.51%
总市值13.01亿	流通市值10.59亿	总股本1.55亿
成交额2,287万	换手率2.16%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":8.4,"timestamp":1721160000000,"preClose":8.43,"halted":0,"volume":2720213,"hourTrading":{"tag":"盘后","latestPrice":8.3,"preClose":8.4,"latestTime":"19:37 EDT","volume":221552,"amount":1860998.693056,"timestamp":1721173037103},"delay":0,"floatShares":126095189,"shares":154888915,"eps":-1.299432,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.03,"latestTime":"07-16 19:46:24 EDT","open":8.535,"high":8.68,"low":8.3,"amount":22873261.917976998,"amplitude":0.045077,"askPrice":8.6,"askSize":60,"bidPrice":7.89,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-1.299432,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721174400000},"adr":0,"listingDate":1406260800000,"adjPreClose":8.43,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":8.59,"preClose":8.43,"latestTime":"09:25 EDT","volume":532,"amount":4548.655328,"timestamp":1721136345619},"postHourTrading":{"tag":"盘后","latestPrice":8.3,"preClose":8.4,"latestTime":"19:37 EDT","volume":221552,"amount":1860998.693056,"timestamp":1721173037103},"volumeRatio":1.427865,"impliedVol":1.0334,"impliedVolPercentile":0.7381},"requestUrl":"/m/hq/s/OCUL","defaultTab":"news","newsList":[{"id":"2450685531","title":"Ocular Therapeutix, Inc.盘中异动 早盘快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450685531","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450685531?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:12","pubTimestamp":1720793531,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时12分，Ocular Therapeutix, Inc.股票出现波动，股价快速上涨5.13%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。消息层面，截至22时12分，《Form 144 | Ocular Therapeutix高管拟出售3.84万股股份，价值约25.19万美元》资讯为影响Ocular Therapeutix, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221211af921e94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712221211af921e94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2450848281","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450848281","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450848281?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:28","pubTimestamp":1720628935,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时28分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.04%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。消息层面，截至00时28分，《Form 144 | Ocular Therapeutix高管拟出售3.84万股股份，价值约25.19万美元》资讯为影响Ocular Therapeutix, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002856af91a1e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711002856af91a1e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2445003839","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.12%报6.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445003839","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445003839?lang=zh_cn&edition=full","pubTime":"2024-06-24 22:39","pubTimestamp":1719239951,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日22时39分，Ocular Therapeutix, Inc.股票出现波动，股价急速拉升5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、阿里拉姆制药、Altimmune, Inc.涨幅较大，Revelation Biosciences, Inc.、Geovax Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1692.64%、129.57%、74.84%，振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.，振幅分别为139.27%、59.54%、58.29%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062422391196816450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062422391196816450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2434772745","title":"摩根大通证券公司：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由24.00美元调整至22.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434772745","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434772745?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:15","pubTimestamp":1715192127,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价由24.00美元调整至22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902153087e1437c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050902153087e1437c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2433588387","title":"Ocular Therapeutix Inc 报告截至三月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433588387","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433588387?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:01","pubTimestamp":1715115697,"startTime":"0","endTime":"0","summary":"   * Ocular Therapeutix Inc   报告，在截至3月底的季度调整后每股亏损49美分，低于去年同期的每股收益-39美分。八位分析师对该季度的平均预期是每股亏损 19 美分。华尔街预期为每股-31美分至-14美分。* Ocular Therapeutix Inc公布的本季度每股收益为亏损49美分。* Ocular Therapeutix Inc 本季度股价下跌了 36.3%，今年迄今为止上涨了 30.0%。5月7日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测上升了约 21%。华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 15.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2433761834","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433761834","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433761834?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:30","pubTimestamp":1715002247,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时30分，Ocular Therapeutix, Inc.股票出现波动，股价快速下跌5.35%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tc Biopharm  Plc、Effector Therapeutics Inc C/Wts 31/12/2025 、BioCryst制药涨幅较大，Allarity Therapeutics, Inc.、Tc Biopharm  Plc、Plus Therapeutics, Inc.较为活跃，换手率分别为480.08%、137.45%、39.42%，振幅较大的相关个股有Passage Bio, Inc.、Dianthus Therapeutics, Inc.、Vaxxinity, Inc.，振幅分别为11.45%、7.09%、4.18%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621304787e85cf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050621304787e85cf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2432977830","title":"Ocular Therapeutix Inc    预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432977830","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432977830?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:17","pubTimestamp":1714742223,"startTime":"0","endTime":"0","summary":"   * Ocular Therapeutix Inc     预计将在 5 月 7 日公布截至 0001 年 1 月 1 日的季度收入报告。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马萨诸塞州贝德福德的公司的营收预计将从去年同期的1337万美元增长15.3%，达到1541.4万美元。* LSEG 分析师对 Ocular Therapeutix Inc 的平均预期是每股亏损 19 美分。* 华尔街对 Ocular Therapeutix Inc 的 12 个月目标价中位数为 15.00 美元，高于其上次收盘价 5.87 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2432360266","title":"Ocular Therapeutix, Inc.盘中异动 早盘急速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432360266","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432360266?lang=zh_cn&edition=full","pubTime":"2024-05-02 22:01","pubTimestamp":1714658507,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日22时01分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.18%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Allarity Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aptevo Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为2642.04%、462.67%、117.88%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Aptevo Therapeutics Inc.，振幅分别为75.18%、39.01%、33.33%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222014787e85576&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050222014787e85576&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2432577406","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432577406","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432577406?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:33","pubTimestamp":1714570395,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时33分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.06%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Cytomx Therapeutics, Inc.、Palisade Bio, Inc.、Tg Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为395.11%、32.02%、13.17%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、万春医药、Akari Therapeutics Plc，振幅分别为16.56%、13.72%、13.63%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012133157a57db47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012133157a57db47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2431186865","title":"Ocular Therapeutix, Inc.盘中异动 股价大涨5.37%报5.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431186865","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431186865?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:39","pubTimestamp":1714397974,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时39分，Ocular Therapeutix, Inc.股票出现波动，股价快速拉升5.37%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Soleno Therapeutics, Inc.、Immunitybio, Inc.、Cassava Sciences Inc C/Wts 15/11/2024涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为565.10%、25.59%、12.13%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Soleno Therapeutics, Inc.，振幅分别为33.33%、17.43%、14.62%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292139357a572906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292139357a572906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2430887287","title":"Ocular Therapeutix, Inc.盘中异动 急速上涨5.12%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430887287","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430887287?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:37","pubTimestamp":1714149420,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时37分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.12%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Biodexa Pharmaceuticals Plc、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1379.93%、119.65%、47.48%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为82.78%、81.90%、66.85%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700370079240e35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042700370079240e35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2430286746","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.06%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430286746","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430286746?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:30","pubTimestamp":1714051837,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时30分，Ocular Therapeutix, Inc.股票出现波动，股价急速下跌5.06%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。其相关个股中，Processa Pharmaceuticals, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Zura Bio Limited C/Wts 涨幅较大，Processa Pharmaceuticals, Inc.、Cyclacel Pharmaceuticals, Inc.、Cidara Therapeutics, Inc.较为活跃，换手率分别为401.29%、176.80%、5.03%，振幅较大的相关个股有Processa Pharmaceuticals, Inc.、Renovaro Inc.、Cidara Therapeutics, Inc.，振幅分别为6.17%、4.57%、3.74%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521303887e83adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521303887e83adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2428654518","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大跌5.03%报5.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428654518","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428654518?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:32","pubTimestamp":1713533559,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日21时32分，Ocular Therapeutix, Inc.股票出现异动，股价大幅下跌5.03%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。该信息摘要如下：HC Wainwright & Co.：重申Ocular Therapeutix评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213240861e7738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419213240861e7738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"None","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2428347816","title":"HC Wainwright & Co.：重申Ocular Therapeutix(OCUL.US)评级，由买入调整至买入评级, 目标价16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2428347816","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428347816?lang=zh_cn&edition=full","pubTime":"2024-04-19 18:35","pubTimestamp":1713522939,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Ocular Therapeutix(OCUL.US)评级，由买入调整至买入评级, 目标价16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419183542879555cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419183542879555cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2427715108","title":"摩根大通证券公司：重申Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价24.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2427715108","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427715108?lang=zh_cn&edition=full","pubTime":"2024-04-16 23:25","pubTimestamp":1713281127,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申Ocular Therapeutix(OCUL.US)评级，由优于大市调整至优于大市评级, 目标价24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162325318b2ae9fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162325318b2ae9fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL"],"gpt_icon":0},{"id":"2427888682","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.01%报7.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427888682","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427888682?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:42","pubTimestamp":1713195753,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时42分，Ocular Therapeutix, Inc.股票出现波动，股价大幅下跌5.01%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。其相关个股中，安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 、Soligenix, Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1418.99%、1125.57%、806.21%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、95.78%、80.04%。Ocular Therapeutix, Inc.公司简介：Oural Therapeutix Inc 是一家生物技术公司，专门从事眼部疾病和病症的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415234234861e5db6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240415234234861e5db6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2426491711","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426491711","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426491711?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:30","pubTimestamp":1712755841,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日21时30分，Ocular Therapeutix, Inc.股票出现异动，股价急速下挫5.63%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Vbi Vaccines, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Abvc Biopharma, Inc.较为活跃，换手率分别为743.01%、61.89%、20.18%，振幅较大的相关个股有Elicio Therapeutics, Inc.、Oragenics Inc.、Jaguar Health, Inc.，振幅分别为7.05%、5.51%、5.44%。Ocular Therapeutix, Inc.公司简介：Ocular Therapeutix Inc是一家生物技术公司，专门从事眼疾疾病和病症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021304187e7f46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041021304187e7f46a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2425500915","title":"Ocular Therapeutix, Inc.盘中异动 早盘股价大跌5.21%报8.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425500915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2425500915?lang=zh_cn&edition=full","pubTime":"2024-04-08 22:00","pubTimestamp":1712584812,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日22时00分，Ocular Therapeutix, Inc.股票出现异动，股价急速下跌5.21%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Longeveron Inc.、阿诺医药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Longeveron Inc.、Allarity Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为991.98%、699.89%、53.82%，振幅较大的相关个股有Longeveron Inc.、Palatin Technologies, Inc.、阿诺医药，振幅分别为103.99%、28.98%、28.70%。Ocular Therapeutix, Inc.公司简介：Ocular Therapeutix Inc是一家生物技术公司，专门从事眼疾疾病和病症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822001287e7e8f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040822001287e7e8f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2424392716","title":"Ocular Therapeutix, Inc.盘中异动 早盘大幅拉升5.03%报8.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424392716","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424392716?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:50","pubTimestamp":1712238646,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时50分，Ocular Therapeutix, Inc.股票出现异动，股价急速拉升5.03%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Tc Biopharm  Plc、Candel Therapeutics, Inc.、Eiger Biopharmaceuticals, Inc.较为活跃，换手率分别为1893.16%、30.42%、22.72%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为90.00%、70.00%、42.86%。Ocular Therapeutix, Inc.公司简介：Ocular Therapeutix Inc是一家生物技术公司，专门从事眼疾疾病和病症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215046791ecd4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404215046791ecd4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2421825842","title":"Ocular Therapeutix, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421825842","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421825842?lang=zh_cn&edition=full","pubTime":"2024-03-23 02:12","pubTimestamp":1711131179,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日02时12分，Ocular Therapeutix, Inc.股票出现异动，股价快速下跌5.02%。Ocular Therapeutix, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Effector Therapeutics Inc C/Wts 31/12/2025 、Virios Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、Adial Pharmaceuticals, Inc、180 Life Sciences Corp.较为活跃，换手率分别为92.11%、47.08%、42.17%，振幅较大的相关个股有Virios Therapeutics, Inc.、Moolec Science Sa C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为86.19%、75.83%、63.93%。Ocular Therapeutix, Inc.公司简介：Ocular Therapeutix Inc是一家生物技术公司，专门从事眼疾疾病和病症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230212597a4e8ea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230212597a4e8ea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OCUL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ocutx.com","stockEarnings":[{"period":"1week","weight":0.2658},{"period":"1month","weight":0.4661},{"period":"3month","weight":0.0822},{"period":"6month","weight":1.0313},{"period":"1year","weight":0.7673},{"period":"ytd","weight":0.8901}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0345},{"period":"3month","weight":0.1152},{"period":"6month","weight":0.189},{"period":"1year","weight":0.2498},{"period":"ytd","weight":0.1814}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ocular Therapeutix, Inc.于2006年9月12号在特拉华州成立。该公司是一家生物制药公司，致力于对使用该公司专有的水凝胶技术平台眼部疾病和病症的创新疗法的开发和商业化。该公司基于水凝胶的生物可吸收候选产品的设计是给眼睛提供持续的治疗药物缓释。公司的主导候选产品是药物洗脱泪点塞OTX-DP和被插入到一个自然的开口叫坐落在靠近鼻子的眼睑的内侧部分的泪点OTX-TP。公司的泪小管栓候选产品结合了公司的水凝胶技术同美国食品和药物管理局，或FDA批准的治疗药物对眼睛提供持续给药目的。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.018559},{"month":2,"riseRate":0.8,"avgChangeRate":0.25544},{"month":3,"riseRate":0.5,"avgChangeRate":0.026181},{"month":4,"riseRate":0.5,"avgChangeRate":-0.051966},{"month":5,"riseRate":0.6,"avgChangeRate":0.007801},{"month":6,"riseRate":0.4,"avgChangeRate":0.015343},{"month":7,"riseRate":0.4,"avgChangeRate":-0.051298},{"month":8,"riseRate":0.5,"avgChangeRate":0.066915},{"month":9,"riseRate":0.2,"avgChangeRate":-0.10336},{"month":10,"riseRate":0.3,"avgChangeRate":-0.113365},{"month":11,"riseRate":0.7,"avgChangeRate":0.170251},{"month":12,"riseRate":0.5,"avgChangeRate":0.089348}],"exchange":"NASDAQ","name":"Ocular Therapeutix","nameEN":"Ocular Therapeutix"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.0","shortVersion":"4.25.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ocular Therapeutix,OCUL,Ocular Therapeutix股票,Ocular Therapeutix股票老虎,Ocular Therapeutix股票老虎国际,Ocular Therapeutix行情,Ocular Therapeutix股票行情,Ocular Therapeutix股价,Ocular Therapeutix股市,Ocular Therapeutix股票价格,Ocular Therapeutix股票交易,Ocular Therapeutix股票购买,Ocular Therapeutix股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocular Therapeutix(OCUL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ocular Therapeutix(OCUL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}